SCR7, a potent cancer therapeutic agent and a biochemical inhibitor of nonhomologous DNA end-joining.
Meghana ManjunathBibha ChoudharySathees C RaghavanPublished in: Cancer reports (Hoboken, N.J.) (2021)
SCR7 is a potent NHEJ inhibitor with unique properties and wide applications as an anticancer agent. Most importantly, SCR7 has become a handy aid for improving genome editing across different model systems.